2007
DOI: 10.2174/157489007782418973
|View full text |Cite
|
Sign up to set email alerts
|

HDL Elevation and Lipid Lowering Therapy: Current Scenario and Future Perspectives

Abstract: High density lipoprotein (HDL) has proven its role in reverse cholesterol transport and cellular cholesterol efflux thus acting as a protective factor against atherogenic cardiovascular diseases. The article focuses primarily on structure and function of genes influencing HDL metabolism. Various novel targets involve liver X receptor, retinoid X receptor, peroxisome proliferators activated receptor agonists and apoA-I mimetics. New molecules targeting these nuclear receptors are described. Phospholipid transfe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 249 publications
(234 reference statements)
0
2
0
Order By: Relevance
“…HDL is known as “good cholesterol” given the inverse correlation between HDL levels and the incidences of cardiovascular disease. Until recently, raising circulating HDL levels has been thought of as a treatment for arteriosclerosis, while today increasing specific functional forms of HDL, and not just total HDL levels, is considered a more viable treatment (Joy and Hegele, 2008; Chhabria et al, 2007). Puzzling in this regard is that HDL particles upon lipidation form a wide range of shapes and sizes, with the ability to transform from lipid-poor globular proteins to discoidal and to spherical particles.…”
Section: Introductionmentioning
confidence: 99%
“…HDL is known as “good cholesterol” given the inverse correlation between HDL levels and the incidences of cardiovascular disease. Until recently, raising circulating HDL levels has been thought of as a treatment for arteriosclerosis, while today increasing specific functional forms of HDL, and not just total HDL levels, is considered a more viable treatment (Joy and Hegele, 2008; Chhabria et al, 2007). Puzzling in this regard is that HDL particles upon lipidation form a wide range of shapes and sizes, with the ability to transform from lipid-poor globular proteins to discoidal and to spherical particles.…”
Section: Introductionmentioning
confidence: 99%
“…There is now great interest in identifying new agents for raising HDL or for improving its function, with the expectation that a combined approach of simultaneously lowering LDL and raising HDL will be more effective in reducing cardiovascular events than only lowering LDL, which in most trials reduces clinical events by only approximately 30% [25]. Currently, the most effective drug for increasing HDL is niacin but its use has been limited because of side effects, although newer slower release formulations of niacin coupled with selective prostaglandin D2 receptor antagonists may ameloriate this problem [6].…”
mentioning
confidence: 99%